- Home
- BDTX vs PINE Comparison
BDTX vs PINE Comparison
Compare BDTX & PINE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDTX
- PINE
- Stock Information
- Founded
- BDTX 2014
- PINE 2019
- Country
- BDTX United States
- PINE United States
- Employees
- BDTX N/A
- PINE 4
- Industry
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- PINE Real Estate Investment Trusts
- Sector
- BDTX Health Care
- PINE Real Estate
- Exchange
- BDTX Nasdaq
- PINE Nasdaq
- Market Cap
- BDTX 181.4M
- PINE 205.4M
- IPO Year
- BDTX 2020
- PINE 2019
- Fundamental
- Price
- BDTX $3.80
- PINE $14.46
- Analyst Decision
- BDTX Strong Buy
- PINE Strong Buy
- Analyst Count
- BDTX 5
- PINE 3
- Target Price
- BDTX $10.40
- PINE $17.17
- AVG Volume (30 Days)
- BDTX 904.0K
- PINE 105.9K
- Earning Date
- BDTX 11-05-2025
- PINE 10-23-2025
- Dividend Yield
- BDTX N/A
- PINE 7.86%
- EPS Growth
- BDTX N/A
- PINE N/A
- EPS
- BDTX 0.25
- PINE N/A
- Revenue
- BDTX $70,000,000.00
- PINE $57,423,000.00
- Revenue This Year
- BDTX N/A
- PINE $14.37
- Revenue Next Year
- BDTX N/A
- PINE $0.71
- P/E Ratio
- BDTX $15.26
- PINE N/A
- Revenue Growth
- BDTX N/A
- PINE 14.81
- 52 Week Low
- BDTX $1.20
- PINE $13.10
- 52 Week High
- BDTX $4.45
- PINE $18.57
- Technical
- Relative Strength Index (RSI)
- BDTX 49.08
- PINE 63.16
- Support Level
- BDTX $3.67
- PINE $13.63
- Resistance Level
- BDTX $4.08
- PINE $14.80
- Average True Range (ATR)
- BDTX 0.24
- PINE 0.28
- MACD
- BDTX -0.06
- PINE 0.14
- Stochastic Oscillator
- BDTX 10.26
- PINE 85.56
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
About PINE Alpine Income Property Trust Inc.
Alpine Income Property Trust Inc is a real estate investment trust (REIT) that owns and operates a high-quality portfolio of commercial net lease properties in the United States. The company's portfolio predominantly comprises single-tenant retail properties located in or near metropolitan statistical areas, or MSAs. It operates in two business segments: income properties, which derive maximum revenue, and commercial loans and investments.